Ion channels as targets to treat cystic fibrosis lung disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Cystic Fibrosis Année : 2018

Ion channels as targets to treat cystic fibrosis lung disease

Résumé

Lung health relies on effective mucociliary clearance and innate immune defence mechanisms. In cystic fibrosis (CF), an imbalance in ion transport due to an absence of chloride ion secretion, caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) and a concomitant sodium hyperabsorption, caused by dyregulation of the epithelial sodium channel (ENaC), results in mucus stasis which predisposes the lungs to cycles of chronic infection and inflammation leading to lung function decline. An increased understanding of CFTR structure and function has provided opportunity for the development of a number of novel modulators targeting mutant CFTR however, it is important to also consider other ion channels and transporters present in the airways as putative targets for drug development. In this review, we discuss recent advances in CFTR biology which will contribute to further drug discovery in the field. We also examine developments to inhibit the epithelial sodium channel (ENaC) and potentially activate alternative chloride channels and transporters as a multi-tracked strategy to hydrate CF airways and restore normal mucociliary clearance mechanisms in a manner independent of CFTR mutation.
Fichier principal
Vignette du fichier
2017 Martin JCF.pdf (535.47 Ko) Télécharger le fichier
Origine : Accord explicite pour ce dépôt
Loading...

Dates et versions

hal-02385564 , version 1 (28-11-2019)

Identifiants

Citer

S. Lorraine Martin, Vinciane Saint-Criq, Tzyh-Chang Hwang, László Csanády. Ion channels as targets to treat cystic fibrosis lung disease. Journal of Cystic Fibrosis, 2018, 17 (2), pp.S22-S27. ⟨10.1016/j.jcf.2017.10.006⟩. ⟨hal-02385564⟩
20 Consultations
92 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More